JKT-1 is not a human seminoma cell line - PubMed
doi: 10.1111/j.1365-2605.2007.00802.x.
Hans Stoop, Ad J M Gillis, Ruud J H L M van Gurp, Ellen van Drunen, H Berna Beverloo, Yun-Fai Chris Lau, Dominik T Schneider, Jon K Sherlock, John Baeten, Shingo Hatakeyama, Chikara Ohyama, J Wolter Oosterhuis, Leendert H J Looijenga
Affiliations
- PMID: 17705808
- DOI: 10.1111/j.1365-2605.2007.00802.x
JKT-1 is not a human seminoma cell line
Jeroen de Jong et al. Int J Androl. 2007 Aug.
Abstract
The JKT-1 cell line has been used in multiple independent studies as a representative model of human testicular seminoma. However, no cell line for this specific tumour type has been independently confirmed previously; and therefore, the seminomatous origin of JKT-1 must be proven. The genetic constitution of the JKT-1 cells was determined using flow cytometry and spectral karyotyping, as well as array comparative genomic hybridization and fluorescent in situ hybridization. Marker profiling, predominantly based on differentially expressed proteins during normal germ cell development, was performed by immunohistochemistry and Western blot analyses. Moreover, genome wide affymetrix mRNA expression and profiling of 157 microRNAs was performed, and the status of genomic imprinting was determined. A germ cell origin of the JKT-1 cells was in line with genomic imprinting status and marker profile (including positive staining for several cancer-testis antigens). However, the supposed primary tumour, from which the cell line was derived, being indeed a classical seminoma, was molecularly proven not to be the origin of the cell line. The characteristic chromosomal anomalies of seminoma, e.g. gain of the short arm of chromosome 12, as well as the informative marker profile (positive staining for OCT3/4, NANOG, among others) were absent in the various JKT-1 cell lines investigated, irrespective of where the cells were cultured. All results indicate that the JKT-1 cell line is not representative of human seminoma. Although it can originate from an early germ cell, a non-germ cell derivation cannot be excluded.
Similar articles
-
Bouskine A, Vega A, Nebout M, Benahmed M, Fénichel P. Bouskine A, et al. Int J Androl. 2010 Feb;33(1):54-63. doi: 10.1111/j.1365-2605.2009.00950.x. Epub 2009 Feb 10. Int J Androl. 2010. PMID: 19226408
-
Further characterization of the first seminoma cell line TCam-2.
de Jong J, Stoop H, Gillis AJ, Hersmus R, van Gurp RJ, van de Geijn GJ, van Drunen E, Beverloo HB, Schneider DT, Sherlock JK, Baeten J, Kitazawa S, van Zoelen EJ, van Roozendaal K, Oosterhuis JW, Looijenga LH. de Jong J, et al. Genes Chromosomes Cancer. 2008 Mar;47(3):185-96. doi: 10.1002/gcc.20520. Genes Chromosomes Cancer. 2008. PMID: 18050305
-
Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors.
De Jong J, Weeda S, Gillis AJ, Oosterhuis JW, Looijenga LH. De Jong J, et al. Oncol Rep. 2007 Jul;18(1):127-32. Oncol Rep. 2007. PMID: 17549357
-
Looijenga LH, Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis JW. Looijenga LH, et al. Ann N Y Acad Sci. 2007 Dec;1120:187-214. doi: 10.1196/annals.1411.000. Epub 2007 Oct 2. Ann N Y Acad Sci. 2007. PMID: 17911410 Review.
-
Looijenga LH. Looijenga LH. J Pathol. 2009 Jun;218(2):146-62. doi: 10.1002/path.2522. J Pathol. 2009. PMID: 19253916 Review.
Cited by
-
Cyclic AMP and c-KIT signaling in familial testicular germ cell tumor predisposition.
Azevedo MF, Horvath A, Bornstein ER, Almeida MQ, Xekouki P, Faucz FR, Gourgari E, Nadella K, Remmers EF, Quezado M, de Alexandre RB, Kratz CP, Nesterova M, Greene MH, Stratakis CA. Azevedo MF, et al. J Clin Endocrinol Metab. 2013 Aug;98(8):E1393-400. doi: 10.1210/jc.2012-2838. Epub 2013 Jun 14. J Clin Endocrinol Metab. 2013. PMID: 23771924 Free PMC article.
-
Russell SM, Lechner MG, Mokashi A, Megiel C, Jang JK, Taylor CR, Looijenga LH, French CA, Epstein AL. Russell SM, et al. Urology. 2013 Feb;81(2):464.e1-9. doi: 10.1016/j.urology.2012.09.029. Urology. 2013. PMID: 23374840 Free PMC article.
-
Eckert D, Biermann K, Nettersheim D, Gillis AJ, Steger K, Jäck HM, Müller AM, Looijenga LH, Schorle H. Eckert D, et al. BMC Dev Biol. 2008 Nov 7;8:106. doi: 10.1186/1471-213X-8-106. BMC Dev Biol. 2008. PMID: 18992153 Free PMC article.
-
Cancer stem cells as targets for cancer therapy: selected cancers as examples.
Hombach-Klonisch S, Paranjothy T, Wiechec E, Pocar P, Mustafa T, Seifert A, Zahl C, Gerlach KL, Biermann K, Steger K, Hoang-Vu C, Schulze-Osthoff K, Los M. Hombach-Klonisch S, et al. Arch Immunol Ther Exp (Warsz). 2008 May-Jun;56(3):165-80. doi: 10.1007/s00005-008-0023-4. Epub 2008 May 30. Arch Immunol Ther Exp (Warsz). 2008. PMID: 18512024 Free PMC article. Review.
-
Gan YU, Yang J, Wang Y, Tan Z, Jiang X, Tang Y. Gan YU, et al. Oncol Lett. 2015 Jul;10(1):61-66. doi: 10.3892/ol.2015.3219. Epub 2015 May 18. Oncol Lett. 2015. PMID: 26170977 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials